Q-linea AB (publ) (QLINEA.ST)

SEK 0.97

(-1.62%)

Revenue Summary of Q-linea AB (publ)

  • Q-linea AB (publ)'s latest annual revenue in 2023 was 4.44 Million SEK , down -65.28% from previous year.
  • Q-linea AB (publ)'s latest quarterly revenue in 2024 Q2 was 159 Thousand SEK , down -89.23% from previous quarter.
  • Q-linea AB (publ) reported a annual revenue of 12.78 Million SEK in annual revenue 2022, up 36.99% from previous year.
  • Q-linea AB (publ) reported a annual revenue of 9.33 Million SEK in annual revenue 2021, up 3741.56% from previous year.
  • Q-linea AB (publ) reported a quarterly revenue of 159 Thousand SEK for 2024 Q2, down -89.23% from previous quarter.
  • Q-linea AB (publ) reported a quarterly revenue of 1.35 Million SEK for 2023 Q2, up 6072.73% from previous quarter.

Annual Revenue Chart of Q-linea AB (publ) (2023 - 2016)

Historical Annual Revenue of Q-linea AB (publ) (2023 - 2016)

Year Revenue Revenue Growth
2023 4.44 Million SEK -65.28%
2022 12.78 Million SEK 36.99%
2021 9.33 Million SEK 3741.56%
2020 243 Thousand SEK -75.82%
2019 1 Million SEK -5.72%
2018 1.06 Million SEK -28.93%
2017 1.5 Million SEK 1751.85%
2016 81 Thousand SEK 0.0%

Peer Revenue Comparison of Q-linea AB (publ)

Name Revenue Revenue Difference
AddLife AB (publ) 9.68 Billion SEK 99.954%
Biotage AB (publ) 1.86 Billion SEK 99.762%
Bonesupport Holding AB (publ) 591.07 Million SEK 99.249%
Doxa AB (publ) 9.9 Million SEK 55.152%
Elekta AB (publ) 18.11 Billion SEK 99.975%
iZafe Group AB (publ) 1.82 Million SEK -143.688%
Ortivus AB (publ) 84.08 Million SEK 94.719%
Ortivus AB (publ) 84.08 Million SEK 94.719%
S2Medical AB (publ) 6.97 Million SEK 36.311%
Synsam AB (publ) 5.9 Billion SEK 99.925%